Description
GLP-1/GIP/GLUCAGON 15mg – Research-Grade Peptide for GLP-1, GIP & Glucagon Receptor and Receptor Pathway Studies
Delivery: Laboratory Research-Grade, 15mg Vial, 99.89%
GLP-1/GIP/GLUCAGON 15mg is a synthetic, research-grade peptide designed for advanced laboratory studies focused on GLP-1, GIP, and glucagon receptor signaling, receptor signalling pathways, and multi-receptor peptide biology. It is widely used in experimental investigations exploring receptor interactions, cellular signaling mechanisms, and receptor signalling in controlled scientific models.
This product is strictly for research purposes only and is not approved for human consumption, clinical, or veterinary use.
What Is GLP-1/GIP/GLUCAGON?
GLP-1/GIP/GLUCAGON is a synthetic peptide that functions as a triple receptor agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. In laboratory research, GLP-1/GIP/GLUCAGON is studied to investigate:
• Peptide–receptor binding and signaling mechanisms
• Multi-receptor pathway modulation in cellular models
• Receptor signalling at the molecular level
• Experimental studies of GLP-1, GIP, and glucagon receptor interactions
All applications are strictly non-clinical and intended for scientific research only.
Research Applications of GLP-1/GIP/GLUCAGON 15mg
GLP-1/GIP/GLUCAGON 15mg is suitable for laboratory research, including:
• Multi-Receptor Signaling Studies – Mechanistic investigations of GLP-1, GIP, and glucagon receptor activity
• Receptor Pathway Research – Examining peptide effects on insulin signaling, glucose handling, and energy regulation
• Peptide Pharmacology & Biology – Studying synthetic peptide activity in vitro or ex vivo
• Experimental Endocrine Models – Controlled studies of hormone receptor-mediated signaling
• Dose-Response & Multi-Dose Studies – Laboratory evaluation for mechanistic and long-term investigations
All uses are strictly limited to research purposes.
Product Specifications
• Peptide: GLP-1/GIP/GLUCAGON
• Concentration: 15mg per vial
• Grade: Research-Grade
• Storage: Maintain according to standard peptide laboratory protocols
The 15mg format is optimized for mid-scale to large-scale studies, repeat-exposure experiments, and mechanistic experiments.
Purity & Quality Assurance
ExoLabz peptides are produced under strict quality control standards. ExoLabz products undergo independent third-party testing to verify identity, purity, and content. Results are published on this site.
Researchers may submit the peptide for independent verification. If specifications are not met, ExoLabz provides a refund and testing reimbursement, ensuring full research integrity.
Important Legal Disclaimer
For Research Purposes Only
GLP-1/GIP/GLUCAGON 15mg is intended strictly for scientific research and laboratory use. It is not approved by the FDA, Health Canada, or any other regulatory authority. This product is not for human consumption, clinical, therapeutic, or veterinary use.
By purchasing this product, you agree to use it exclusively for lawful laboratory research purposes.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Willard FS, et al. JCI Insight. 2020;5(17):e140532. In HEK293 and CHO-K1 cells, measured competition radioligand binding, cAMP accumulation, beta-arrestin recruitment and receptor internalisation at human GIPR and GLP-1R. Source · PMID 32730231
- Zhao F, et al. Nat Commun. 2022;13:1057. Solved five cryo-EM structures of Gs-coupled GIPR, GLP-1R and GCGR at 3.0-3.5 A and measured cAMP potency across site-directed receptor mutants. Source · PMID 35217653
- Knerr PJ, et al. Mol Metab. 2022;63:101533. Rodent study comparing triagonists with tuned GLP-1R/GIPR/GCGR potency ratios; see the linked record for methods and endpoints. Source · PMID 35809773
Literature notes: References concern receptor pharmacology and preclinical models. Clinical literature is outside the scope of this list.
Related Research Compounds
Browse more compounds in Incretin & Glucagon Peptides, or view the full research peptide catalogue.
